Official ESCRS | European Society of Cataract & Refractive Surgeons
Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits


escrs app advert yo advert

Outcomes of a trifocal intraocular lens implantation: results of a prospective clinical trial

Search Title by author or title

Session Details

Session Title: Pseudophakic IOLs: Multifocal I

Session Date/Time: Monday 12/09/2016 | 08:00-10:30

Paper Time: 08:18

Venue: Auditorium A

First Author: : I.Bahar ISRAEL

Co Author(s): :                        

Abstract Details


To report the visual outcomes in patients with cataract surgery and bilateral implantation of a trifocal intraocular lens (IOL) in a prospective clinical trial.


Ophthalmology Department, Rabin Medical Center, Petach Tiqva, Israel


Patients with cataract and less than 0.75 diopter (D) of corneal astigmatism were enrolled to the study and received bilateral implantation of Finevision Pod F trifocal IOLs. Outcome measures included monocular and binocular uncorrected and best corrected distance (UDVA), intermediate (UIVA), and near (UNVA) visual acuities in photopic and mesopic conditions ; refractive outcomes; binocular defocus curve; and spectacle independence.


Three months postoperatively, the mean binocular photopic UDVA, UIVA, and UNVA in 20 eyes of 10 patients were 0. 1 logMAR ± 0.11 (SD), 0.05 ± 0.05 logMAR, and 0.02 ± 0.03 logMAR, respectively. Preoperative spherical equivalent (SE) was +0.21±2.02 D (range : -3.88 to +1.75D) and postoperative spherical equivalent was -0.18±0.31 (range: -0.75 to 0.13 D) The trifocal defocus curve showed vision of 0.2 logMAR or better in the range of +1.5D to -2.5 D of defocus. Complete spectacle independence was reported by 90% of patients.


This study showed excellent visual outcomes with the trifocal IOL, with very good outcomes at the intermediate and near distance.

Financial Disclosure:

... research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, ... travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented

Back to previous